Central Drugs Standard Control Organisation (CDSCO) extends validity of WHO GMP/CoPP expiring from March to August 2020 by 6 months due to COVID-19 outbreak in the country.
Certificate of Pharmaceutical Product (CoPP) is issued under the WHO GMP Certification Scheme for the purpose of international commerce which is for registration of products in foreign countries. Earlier the validity of CoPP was extended from 2 years to 3 years by CDSCO.
CDSCO had received representations from certificate holders requesting to extend validity of WHO GMP Certificate/CoPP whose validities are expiring between now and August 2020 in view of COVID-19 outbreak.
It had been examined by CDSCO in light of current situation of COVID 19 outbreak and in order to maintain the continuity of essential activities by the pharmaceutical industry. And it has been decided that validity of WHO GMP/CoPP expiring from March to August 2020 may be extended by 6 months from the date of expiry of the certificate as per WHO GMP Certification guidelines.
